Locations
Durham, NC, USA
industry
Biotechnology · DeepTech · Health
Size
51-200 employees
Stage
Series A
founded in
2019
Xilis is a biotechnology company focused on revolutionizing precision oncology through its Micro Organo Sphere (MOS) technology. This platform enables personalized treatment decisions by predicting patient responses and guiding optimal therapeutic options, thus transforming cancer drug development. By providing scalable patient-derived models for high-throughput drug discovery, Xilis aims to improve treatment outcomes for cancer patients and accelerate the development of novel therapeutics. The company is positioned to address the growing need for effective cancer treatments in a market where existing approaches often fail to benefit the majority of patients.
Something looks off?